IceCure Medical
ICCM
13 hedge funds and large institutions have $154K invested in IceCure Medical in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
8% more funds holding
Funds holding: 12 → 13 (+1)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
9% less capital invested
Capital invested by funds: $169K → $154K (-$14.9K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
+$24.6K |
| 2 |
FIA
Foundations Investment Advisors
Phoenix,
Arizona
|
+$19.6K |
| 3 |
Fisher Asset Management
Camas,
Washington
|
+$14.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.82K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$48.3K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$18.7K |
| 3 |
Renaissance Technologies
New York
|
-$12K |
| 4 |
Morgan Stanley
New York
|
-$7.01K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$323 |
ICCM Hedge Fund Activity: Q1 2025 in Review
13 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q1 2025, worth a combined $154K — down 8.8% from $169K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ICCM positions and 3 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was LPL Financial, opening a new position worth an estimated $24.6K. The largest seller was XTX Topco, cutting an estimated $48.3K.
- 13 institutional investors held IceCure Medical (ICCM) as of Q1 2025, up from 12 in Q4 2024.
- Funds reported $154K of IceCure Medical stock for Q1 2025, down 8.8% quarter-over-quarter.
- 4 funds opened new IceCure Medical positions in Q1 2025 and 3 closed out, a net change of +1 holder.
- The largest IceCure Medical buyer in Q1 2025 was LPL Financial, an estimated $24.6K added.
- The largest IceCure Medical seller in Q1 2025 was XTX Topco, an estimated $48.3K sold.
Based on aggregated 13F filings for Q1 2025.